After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Emergent Biosolutions Inc is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Emergent Biosolutions Inc is $399.48M. A total of 1.04 million shares were traded on the day, compared to an average of 1.27M shares.
In the most recent transaction, Katkin Keith sold 7,844 shares of EBS for 6.30 per share on May 23 ’25. After the transaction, the Director now owns 86,431 company shares. In a previous transaction on May 23 ’25, KEITH KATKIN bought 7,844 shares at 6.30 per share.
Among the insiders who bought shares, PAPA JOSEPH C acquired of 60,000 shares on May 13 ’25 at a per-share price of $5.83. This resulted in the President and CEO holding 342,500 shares of EBS after the transaction. In another insider transaction, Fowler Neal Franklin sold 35,000 shares at $5.83 per share on Mar 12 ’25. Company shares held by the Director now total 101,100.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, EBS has a high of $15.10 and a low of $4.02.
As of this writing, EBS has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.67 per share and a lower estimate of -$0.72.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EBS’s latest balance sheet shows that the firm has $576.10M in Cash & Short Term Investments as of fiscal 2021. There were $841.00M in debt and $374.00M in liabilities at the time. Its Book Value Per Share was $10.14, while its Total Shareholder’s Equity was $1.61B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EBS is Buy with a score of 3.67.
